Latest Regulatory Risk News

Page 3 of 32
AdAlta Limited (ASX:1AD) has progressed its ‘East to West’ cellular immunotherapy strategy by securing its first CAR-T asset, advancing Australian manufacturing and US FDA regulatory engagement, while raising A$5.3 million in FY2026 and reporting a net loss of $4.68 million.
Ada Torres
Ada Torres
21 Aug 2026
Prescient Therapeutics cut its net loss by 4.4% to $7 million in FY26 while expanding its PTX-100 Phase 2a trial across three continents and securing key regulatory designations in Europe and the US.
Ada Torres
Ada Torres
21 Aug 2026
Ovanti Limited has launched a 1-for-1 entitlement offer to raise approximately AUD 2.293 million at 0.2 cents per share, targeting working capital and offer costs. The offer closes on 1 September 2026 and includes a top-up facility for additional shares.
Sophie Babbage
Sophie Babbage
21 Aug 2026
Dusk Group delivered record FY26 sales and underlying EBIT growth, driven by product rejuvenation and online momentum, while preparing for international expansion amid ACCC proceedings.
Logan Eniac
Logan Eniac
20 Aug 2026
Auckland Airport posted a 3% revenue increase and a stable underlying profit of NZD 309 million in FY26, driven by robust passenger growth and a $1 billion infrastructure push, while cautioning on near-term fuel price volatility and geopolitical risks.
Victor Sage
Victor Sage
20 Aug 2026
Santos Limited's half-year results show a 19% drop in net profit to US$355 million amid higher production and LNG ramp-up costs, while declaring an interim dividend of 11.6 US cents per share.
Maxwell Dee
Maxwell Dee
19 Aug 2026
The Lottery Corporation reported a resilient FY26 performance despite a rare jackpot drought, extending its Victorian licence by 40 years and unveiling a fresh digital-focused strategy.
Victor Sage
Victor Sage
19 Aug 2026
BHP Group Limited posted robust FY2026 results with a 15% revenue increase, record copper production contributing over half of underlying EBITDA, and a total fully franked dividend of 172 US cents per share. The company advances growth projects, including the Jansen potash mine, while managing legacy Samarco liabilities and pursuing climate targets.
Maxwell Dee
Maxwell Dee
18 Aug 2026
Great Western Exploration (ASX: GTE) has entered a farm-in deal to earn up to 100% of the McKinlay Copper-Gold and Silver Project near Cloncurry, Queensland, targeting Ernest Henry-style IOCG and Cannington-style silver-lead deposits with a planned drilling campaign.
Maxwell Dee
Maxwell Dee
18 Aug 2026
Sinclair Gold has locked in a binding earn-in agreement with Medaro Mining, unlocking up to $3.4 million in combined cash, shares, and exploration funding for its Sala silver-zinc-lead project in Sweden. Sinclair retains a net smelter return royalty and focuses on advancing its Mt Henry gold asset.
Maxwell Dee
Maxwell Dee
17 Aug 2026
James Hardie Industries has been hit with a new class action in Victoria alleging breaches related to forward-looking financial statements made between May and August 2025. The company denies any wrongdoing and plans to defend vigorously.
Victor Sage
Victor Sage
14 Aug 2026
ResMed Inc. posted a 10% rise in fiscal 2026 revenue to $5.65 billion, bolstered by the acquisition of Noctrix Health and an agreement to sell its MatrixCare business. The company continues to invest in AI-powered digital health solutions amid ongoing patent litigation and a shifting regulatory landscape.
Ada Torres
Ada Torres
14 Aug 2026

Browse the archive

Full archive